Labeling for Human Prescription Drug and Biological Products - Implementing the PLR Content and Format Requirements
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 25, 2013
April 24, 2020
c135cd21-e316-4f76-b282-cd06416c3081
Related Documents
Q8(R2) Pharmaceutical Development
Guidance DocumentNovember 20, 2009Center for Drug Evaluation and Research
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
Guidance DocumentMarch 8, 2010Center for Drug Evaluation and Research
Providing Submissions in Electronic Format – Postmarket Non-Expedited ICSRs Technical Questions and Answers
Guidance DocumentJuly 24, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox